Abiopharma

🔍 Trebbi Barbara (Director)

Company: Acadian Asset Management Inc. (AAMI)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Sold 10,260 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: G | equity_swap_involved: 0 | shares_owned_after: 28,797.00 | transaction_form_type: 4
• Acquired 10,260 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: G | equity_swap_involved: 0 | shares_owned_after: 10,260.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,288 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,288.00 | transaction_form_type: 4 | Footnotes: F2, F2, F3, F4, F4

Footnotes:

• F1: These shares are held in a trust for the benefit of the reporting person's child. The reporting person, the reporting person's spouse and a third party are trustees of the trust.
• F2: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc.
• F3: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan.
• F4: On June 12, 2026, the reporting person was granted 1,288 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc.